U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research (CDER)
  5. CDER Offices and Divisions
  6. Office of Neuroscience - Division of Neurology I
  1. CDER Offices and Divisions

Office of Neuroscience - Division of Neurology I

The Division of Neurology I (DNI) regulates and reviews Investigational New Drug (IND) applications and marketing applications for drug and biologic products for the treatment of neurodegenerative disorders, movement disorders, and neuromuscular disorders, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, muscular dystrophy, amyotrophic lateral sclerosis, and spasticity.

Contact Us

Mailing Address

Food and Drug Administration
Center for Drug Evaluation and Research
Division of Neurology (DN I)
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-2250
Fax: (301) 796-9842

OND Office and Division Contact Information (PDF)

Resources For You



Back to Top